Finecure Pharmaceuticals operates a high-capacity manufacturing infrastructure engineered to deliver consistent therapeutic efficacy and supply chain reliability. Spanning five physically independent manufacturing plants, our footprint is defined by advanced automation and structural isolation. We integrate automated process flows with strict unidirectional material movement-minimizing human intervention and maximizing product consistency across billions of units.
Operating as a fully integrated manufacturing hub, these facilities serve as the production engine for our proprietary Branded Rx portfolio—trusted by over 50,000 prescribing healthcare practitioners and stocked by 80,000+ retail pharmacies across India. Simultaneously, this infrastructure provides the high-volume output, clinical-grade consistency, and regulatory execution required to sustain our active commercial presence across 20+ global markets.
Finecure Pharmaceuticals manufactures at four sites under WHO-GMP. Segregation is organised by molecule class rather than by convenience: amoxicillin and amoxicillin-clavulanate in a dedicated plant with a physically isolated block, cephalosporin oral solids in a separate segregated block, cephalosporin injectables in their own inspected to PIC/S GMP standards facility, and nutraceuticals on dedicated lines under ISO 22000. Oral solid dosage manufacture is carried out at a USFDA-inspected OSD site, with an Establishment Inspection Report issued on the close of inspection.
Tablets
Capsules
Powder
Injectables
Powder for oral suspension
Ointments
Registrations
Four sites in Gujarat and Uttarakhand, with what each produces and the accreditations applicable to it.
A dedicated site principally producing amoxicillin-clavulanate and amoxicillin, with a 100% physically isolated block held below 20% relative humidity.
A segregated block for cephalosporin oral solids and a separate inspected to PIC/S GMP standards facility for injectables.
Automated coating, checkweighing and material transfer; 24/7 environmental monitoring; centralised building management.
High-speed lines handling multi-million-unit orders with GS1-compliant serialisation.
Accreditations by facility, and how partner and customer audits are handled.